Kaiser Permanente Addiction Medicine and Recovery Servs
-
Services:
- Private non-profit organization
- TB screening
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Adolescents
- Other languages (excluding Spanish)
- Spanish
- Sign language services for the deaf and hard of hearing
- Seniors
- Adults
- Other contracted prescribing entity
- In-network prescribing entity
- Opioids detoxification
- Benzodiazepines Detoxification
- Alcohol Detoxification
- Medication routinely used during detoxification
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Lofexidine or Clonidine detoxification
- Prescribes naltrexone
- Buprenorphine maintenance
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Professional interventionist/educational consultant
- Screening for tobacco use
- Screening for substance use
- Screening for mental disorders
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Marital/couples counseling
- Group counseling
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Family counseling
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Hmong
- Private health insurance
- Substance use disorder counseling
- Motivational interviewing
- Telemedicine/telehealth therapy
- Trauma-related counseling
- Cognitive behavioral therapy
- Relapse prevention
- Smoking permitted in designated area
- Substance use treatment
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Intensive outpatient treatment
- Outpatient
- Outpatient day treatment or partial hospitalization
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- This facility administers/prescribes medication for alcohol use disorder
- Disulfiram
- Buprenorphine without naloxone
- Non-nicotine smoking/tobacco cessation
- Naltrexone (extended-release, injectable)
- Clonidine
- Buprenorphine with naloxone
- Naltrexone (oral)
- Medication for mental disorders
- Acamprosate (Campral®)
- General Hospital (including VA hospital)
- Discharge Planning
- Naloxone and overdose education
- Aftercare/continuing care
- Mental health services
- Social skills development
- Suicide prevention services
- Domestic violence services, including family or partner
- Case management service
- Integrated primary care services
- Hospital licensing authority
- National Committee for Quality Assurance (NCQA)
- The Joint Commission
- Female
- Male
- Vaping permitted in designated area
Facility Operation (e.g., Private, Public)
Testing
Special Programs/Groups Offered
Language Services
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Detoxification (medical withdrawal) Services
Type of Opioid Treatment
Assessment/Pre-treatment
Education and Counseling Services
Opioid Medications used in Treatment
Other Languages
Payment/Insurance/Funding Accepted
Treatment Approaches
Facility Smoking Policy
Type of Care
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Alcohol Use Disorder Treatment
Pharmacotherapies
Hospitals
Transitional Services
Ancillary Services
License/Certification/Accreditation
Gender Accepted
Facility Vaping Policy






